Bioptimus, a pioneering Parisian biotech firm, has secured $35 million in seed funding to advance its AI foundation model for scientific research. Spearheaded by Sofinnova Partners and Bpifrance Large Venture, the investment round also saw contributions from notable entities like Frst, Cathay Innovation, and influential tech entrepreneur Xavier Niel, among others. The fresh capital will fuel Bioptimus's quest to innovate and potentially transform how research is conducted in the biotechnology realm.